1. Wang Y, Liu M, Pu C: 2014 Chinese guidelines for secondary prevention of ischemic stroke and transient ischemic attack. Int J Stroke 2017, 12:302-320.
2. Catanese L, Tarsia J, Fisher M: Acute Ischemic Stroke Therapy Overview. Circ Res 2017, 120:541-558.
3. Alexandrov AV: Current and future recanalization strategies for acute ischemic stroke. J Intern Med 2010, 267:209-219.
4. Grossman AW, Broderick JP: Advances and challenges in treatment and prevention of ischemic stroke. Ann Neurol 2013, 74:363-372.
5. Sandoval KE, Witt KA: Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008, 32:200-219.
6. Ferraris C, Cavalli R, Panciani PP, Battaglia L: Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours. Int J Nanomedicine 2020, 15:2999-3022.
7. Charabati M, Rabanel JM, Ramassamy C, Prat A: Overcoming the Brain Barriers: From Immune Cells to Nanoparticles. Trends Pharmacol Sci 2020, 41:42-54.
8. Singh M, Jadhav HR: Melatonin: functions and ligands. Drug Discov Today 2014, 19:1410-1418.
9. Ling L, Alattar A, Tan Z, Shah FA, Ali T, Alshaman R, Koh PO, Li S: A Potent Antioxidant Endogenous Neurohormone Melatonin, Rescued MCAO by Attenuating Oxidative Stress-Associated Neuroinflammation. Front Pharmacol 2020, 11:1220.
10. Shah SA, Khan M, Jo MH, Jo MG, Amin FU, Kim MO: Melatonin Stimulates the SIRT1/Nrf2 Signaling Pathway Counteracting Lipopolysaccharide (LPS)-Induced Oxidative Stress to Rescue Postnatal Rat Brain. CNS Neurosci Ther 2017, 23:33-44.
11. Wu IY, Nikolaisen TE, Škalko-Basnet N, di Cagno MP: The Hypotonic Environmental Changes Affect Liposomal Formulations for Nose-to-Brain Targeted Drug Delivery. J Pharm Sci 2019, 108:2570-2579.
12. Fréchou M, Zhang S, Liere P, Delespierre B, Soyed N, Pianos A, Schumacher M, Mattern C, Guennoun R: Intranasal delivery of progesterone after transient ischemic stroke decreases mortality and provides neuroprotection. Neuropharmacology 2015, 97:394-403.
13. Chatterjee B, Gorain B, Mohananaidu K, Sengupta P, Mandal UK, Choudhury H: Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges. Int J Pharm 2019, 565:258-268.
14. Lu X, Zhang Y, Wang L, Li G, Gao J, Wang Y: Development of L-carnosine functionalized iron oxide nanoparticles loaded with dexamethasone for simultaneous therapeutic potential of blood brain barrier crossing and ischemic stroke treatment. Drug Deliv 2021, 28:380-389.
15. Hao R, Sun B, Yang L, Ma C, Li S: RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery. Drug Deliv 2020, 27:772-781.
16. Peredo-Silva L, Fuentes-Retamal S, Sandoval-Acuña C, Pavani M, Maya JD, Castro-Castillo V, Madrid-Rojas M, Rebolledo S, Kemmerling U, Parra E, Ferreira J: Derivatives of alkyl gallate triphenylphosphonium exhibit antitumor activity in a syngeneic murine model of mammary adenocarcinoma. Toxicol Appl Pharmacol 2017, 329:334-346.
17. Guo Q, Xu S, Yang P, Wang P, Lu S, Sheng D, Qian K, Cao J, Lu W, Zhang Q: A dual-ligand fusion peptide improves the brain-neuron targeting of nanocarriers in Alzheimer's disease mice. J Control Release 2020, 320:347-362.
18. Hong HY, Choi JS, Kim YJ, Lee HY, Kwak W, Yoo J, Lee JT, Kwon TH, Kim IS, Han HS, Lee BH: Detection of apoptosis in a rat model of focal cerebral ischemia using a homing peptide selected from in vivo phage display. J Control Release 2008, 131:167-172.
19. Hu JB, Kang XQ, Liang J, Wang XJ, Xu XL, Yang P, Ying XY, Jiang SP, Du YZ: E-selectin-targeted Sialic Acid-PEG-dexamethasone Micelles for Enhanced Anti-Inflammatory Efficacy for Acute Kidney Injury. Theranostics 2017, 7:2204-2219.
20. Wang DW, Li SJ, Tan XY, Wang JH, Hu Y, Tan Z, Liang J, Hu JB, Li YG, Zhao YF: Engineering of stepwise-targeting chitosan oligosaccharide conjugate for the treatment of acute kidney injury. Carbohydr Polym 2021, 256:117556.
21. Xie Y, Liu C, Huang H, Huang J, Deng A, Zou P, Tan X: Bone-targeted delivery of simvastatin-loaded PEG-PLGA micelles conjugated with tetracycline for osteoporosis treatment. Drug Deliv Transl Res 2018, 8:1090-1102.
22. Gallardo-Rivera R, de Los Ángeles Aguilar-Santamaría M, Silva-Bermúdez P, García-López J, Tecante A, Velasquillo C, Román-Guerrero A, Pérez-Alonso C, Vázquez-Torres H, Shirai K: Polyelectrolyte complex of Aloe vera, chitosan, and alginate produced fibroblast and lymphocyte viabilities and migration. Carbohydr Polym 2018, 192:84-94.
23. Liu Y, Xie B, Li L, Zhang X, Zhang Y, He H, Yin T, Tang X, Cai C, Gou J: PEGylated lipid microspheres loaded with cabazitaxel for intravenous administration: stability, bioavailability, antitumor efficacy, and toxicity. Drug Deliv Transl Res 2018, 8:1365-1379.
24. Li F, Gong X, Yang B: Geranylgeranylacetone ameliorated ischemia/reperfusion induced-blood brain barrier breakdown through HSP70-dependent anti-apoptosis effect. Am J Transl Res 2021, 13:102-114.
25. Martins T, Burgoyne T, Kenny BA, Hudson N, Futter CE, Ambrósio AF, Silva AP, Greenwood J, Turowski P: Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells. Neuropharmacology 2013, 65:74-82.
26. Li Z, Pan LL, Zhang FL, Wang Z, Shen YY, Zhang ZZ: Preparation and characterization of fullerene (C60) amino acid nanoparticles for liver cancer cell treatment. J Nanosci Nanotechnol 2014, 14:4513-4518.
27. Liu FH, Hou CY, Zhang D, Zhao WJ, Cong Y, Duan ZY, Qiao ZY, Wang H: Enzyme-sensitive cytotoxic peptide-dendrimer conjugates enhance cell apoptosis and deep tumor penetration. Biomater Sci 2018, 6:604-613.
28. Alsagaby SA, Vijayakumar R, Premanathan M, Mickymaray S, Alturaiki W, Al-Baradie RS, AlGhamdi S, Aziz MA, Alhumaydhi FA, Alzahrani FA, et al: Transcriptomics-Based Characterization of the Toxicity of ZnO Nanoparticles Against Chronic Myeloid Leukemia Cells. Int J Nanomedicine 2020, 15:7901-7921.
29. Hu JB, Li SJ, Kang XQ, Qi J, Wu JH, Wang XJ, Xu XL, Ying XY, Jiang SP, You J, Du YZ: CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage. Carbohydr Polym 2018, 193:268-280.
30. Pénzes M, Túrós D, Máthé D, Szigeti K, Hegedűs N, Rauscher A, Tóth P, Ivic I, Padmanabhan P, Pál G, et al: Direct myosin-2 inhibition enhances cerebral perfusion resulting in functional improvement after ischemic stroke. Theranostics 2020, 10:5341-5356.
31. Jiang Q, Su DY, Wang ZZ, Liu C, Sun YN, Cheng H, Li XM, Yan B: Retina as a window to cerebral dysfunction following studies with circRNA signature during neurodegeneration. Theranostics 2021, 11:1814-1827.
32. Robinson JP, Bruner LH, Bassoe CF, Hudson JL, Ward PA, Phan SH: Measurement of intracellular fluorescence of human monocytes relative to oxidative metabolism. J Leukoc Biol 1988, 43:304-310.
33. Małota K, Student S, Świątek P: Low mitochondrial activity within developing earthworm male germ-line cysts revealed by JC-1. Mitochondrion 2019, 44:111-121.
34. Kazmierczak A, Strosznajder JB, Adamczyk A: alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells. Neurochem Int 2008, 53:263-269.
35. Lv W, Xu J, Wang X, Li X, Xu Q, Xin H: Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment. ACS Nano 2018, 12:5417-5426.
36. Ishii T, Asai T, Urakami T, Oku N: Accumulation of macromolecules in brain parenchyma in acute phase of cerebral infarction/reperfusion. Brain Res 2010, 1321:164-168.
37. Luo Y, Yang H, Zhou YF, Hu B: Dual and multi-targeted nanoparticles for site-specific brain drug delivery. J Control Release 2020, 317:195-215.
38. Wang H, Chang J, Shi M, Pan W, Li N, Tang B: A Dual-Targeted Organic Photothermal Agent for Enhanced Photothermal Therapy. Angew Chem Int Ed Engl 2019, 58:1057-1061.
39. Chen P, Kuang W, Zheng Z, Yang S, Liu Y, Su L, Zhao K, Liang G: Carboxylesterase-Cleavable Biotinylated Nanoparticle for Tumor-Dual Targeted Imaging. Theranostics 2019, 9:7359-7369.
40. Wang B, Zhang W, Zhou X, Liu M, Hou X, Cheng Z, Chen D: Development of dual-targeted nano-dandelion based on an oligomeric hyaluronic acid polymer targeting tumor-associated macrophages for combination therapy of non-small cell lung cancer. Drug Deliv 2019, 26:1265-1279.
41. Huile G, Shuaiqi P, Zhi Y, Shijie C, Chen C, Xinguo J, Shun S, Zhiqing P, Yu H: A cascade targeting strategy for brain neuroglial cells employing nanoparticles modified with angiopep-2 peptide and EGFP-EGF1 protein. Biomaterials 2011, 32:8669-8675.
42. Gao H, Qian J, Cao S, Yang Z, Pang Z, Pan S, Fan L, Xi Z, Jiang X, Zhang Q: Precise glioma targeting of and penetration by aptamer and peptide dual-functioned nanoparticles. Biomaterials 2012, 33:5115-5123.
43. Trendeleva TA, Sukhanova EI, Rogov AG, Zvyagilskaya RA, Seveina, II, Ilyasova TM, Cherepanov DA, Skulachev VP: Role of charge screening and delocalization for lipophilic cation permeability of model and mitochondrial membranes. Mitochondrion 2013, 13:500-506.
44. Milane L, Trivedi M, Singh A, Talekar M, Amiji M: Mitochondrial biology, targets, and drug delivery. J Control Release 2015, 207:40-58.